In the current study, there were increased levels of serum CXCL16 and CRP observed in patients on hemodialysis compared to the controls demonstrating that dialysis treatment and uremia may cause hyperactivation of the immune system leading to an elevation of peripheral markers of immune activation mainly cytokines and chemokines. Here, CXCL16 is linked to uremia.